Loading
A phase 1 trial of BTM-3566 run by Bantam Pharmaceuticals, now recruiting.
BTM-3566 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT07266285 by Bantam Pharmaceuticals, with 30 participants planned, started 2025-12-10. Conditions recorded: Advanced Solid Tumors. Interventions recorded: BTM-3566.
Shares Bantam Pharmaceutical, BTM-3566 and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/